Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
69,617,065
-
Shares change
-
+3,406,465
-
Total reported value, excl. options
-
$964,195,934
-
Value change
-
+$47,548,351
-
Put/Call ratio
-
4.33%
-
Number of buys
-
61
-
Number of sells
-
-36
-
Price
-
$13.85
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2017
129 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q2 2017.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69,617,065 shares
of 183,255,226 outstanding shares and own 38% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (8,643,739 shares), FRANKLIN RESOURCES INC (8,377,589 shares), FMR LLC (8,049,235 shares), JANUS HENDERSON GROUP PLC (5,641,456 shares), Broadfin Capital, LLC (4,418,359 shares), Partner Fund Management, L.P. (3,344,517 shares), BlackRock Inc. (2,796,551 shares), BAKER BROS. ADVISORS LP (2,783,569 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2,309,604 shares), and VANGUARD GROUP INC (2,096,465 shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.